Literature DB >> 15593123

Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies.

Tania K Uren1, Odilia L C Wijburg, Cameron Simmons, Finn-Eirik Johansen, Per Brandtzaeg, Richard A Strugnell.   

Abstract

Secretory IgA (SIgA) is widely held to be responsible for the defense of the mucosae against pathogenics and other potentially harmful agents. In this study, polymeric Ig receptor (pIgR) knockout mice, which lack secretory antibodies (SAb), were used to investigate the role of vaccine-elicited SAb in protection against gastrointestinal bacterial infections. An essential role for specific SAb in protection against Vibrio cholerae was evident from experiments showing that vaccinated pIgR(-/-) mice, but not vaccinated C57BL/6 mice, were susceptible to cholera toxin challenge. Vaccination of C57BL/6 mice with Salmonella typhimurium elicited strong antigen-specific, mucosal responses, which blocked in vitro invasion of epithelia. However, vaccinated C57BL/6 and pIgR(-/-) mice were equally resistant to challenge infection with virulent S. typhimurium. Finally, we investigated the importance of SIgA in protection against recurrent infections with Citrobacter rodentium. Although higher numbers of bacteria were detected early after challenge infection in feces of vaccinated pIgR(-/-) mice compared with vaccinated C57BL/6 mice, both mouse strains showed complete clearance after 9 days. These results suggested that, in immune animals, SIgA is crucial for the protection of gastrointestinal surfaces against secreted bacterial toxins, may inhibit early colonization by C. rodentium, but is not essential for protection against re-infection with S. typhimurium or C. rodentium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15593123     DOI: 10.1002/eji.200425492

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 2.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

3.  CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.

Authors:  Lynn Bry; Manfred Brigl; Michael B Brenner
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Mouse model of oral infection with virulent type A Francisella tularensis.

Authors:  R KuoLee; X Zhao; J Austin; G Harris; J W Conlan; W Chen
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

Review 5.  Regulation of the gut microbiota by the mucosal immune system in mice.

Authors:  Mizuho Hasegawa; Naohiro Inohara
Journal:  Int Immunol       Date:  2014-05-02       Impact factor: 4.823

6.  Enhanced differentiation of intraepithelial lymphocytes in the intestine of polymeric immunoglobulin receptor-deficient mice.

Authors:  Noriko Kato-Nagaoka; Shin-Ichiro Shimada; Yoko Yamakawa; Satoshi Tsujibe; Tomoaki Naito; Hiromi Setoyama; Yohei Watanabe; Kan Shida; Satoshi Matsumoto; Masanobu Nanno
Journal:  Immunology       Date:  2015-06-26       Impact factor: 7.397

7.  Vaccine-induced intestinal immunity to ricin toxin in the absence of secretory IgA.

Authors:  Lori M Neal; Elizabeth A McCarthy; Carolyn R Morris; Nicholas J Mantis
Journal:  Vaccine       Date:  2010-11-27       Impact factor: 3.641

8.  Truncated abrin A chain expressed in Escherichia coli: a promising vaccine candidate.

Authors:  Tao Zhang; Lin Kang; Shan Gao; Hao Yang; Wenwen Xin; Junhong Wang; Maowen Guo; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

9.  The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea.

Authors:  Kathrin Endt; Bärbel Stecher; Samuel Chaffron; Emma Slack; Nicolas Tchitchek; Arndt Benecke; Laurye Van Maele; Jean-Claude Sirard; Andreas J Mueller; Mathias Heikenwalder; Andrew J Macpherson; Richard Strugnell; Christian von Mering; Wolf-Dietrich Hardt
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

10.  Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice.

Authors:  Xinyuan Qiao; Guiwei Li; Xiangqing Wang; Xiaojing Li; Min Liu; Yijing Li
Journal:  BMC Microbiol       Date:  2009-12-04       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.